MASS - NASDAQ
908 Devices Inc.
$8.66
-2.1%908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
At a Glance
Live Snapshot908 Devices Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Exceptional profitability. The company converts a significant portion of revenue to bottom-line earnings.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
908 Devices Inc. Income Statement
MASS • NASDAQ
| 908 Devices Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
56.2M | 59.6M | 50.2M | 46.9M | 42.2M | 26.9M | 18M | 22.1M | |
GROSS PROFIT | ||||||||
(27.8M) | (29.7M) | (24.9M) | (20.8M) | (19M) | (12M) | (9.8M) | (9.7M) | |
28.4M | 29.9M | 25.3M | 26M | 23.2M | 14.9M | 8.1M | 12.4M | |
OPERATING INCOME | ||||||||
(67.8M) | (106.6M) | (68.1M) | (61.4M) | (45.3M) | (20.7M) | (20.3M) | (18.8M) | |
(38.5M) | (0.0) | (0.0) | (43.9M) | (32.2M) | (0.0) | (11.3M) | (9.3M) | |
(15.6M) | (25.5M) | (21.9M) | (17.5M) | (13.1M) | (8.2M) | (9M) | (9.5M) | |
-39.4M | -76.7M | -42.8M | -35.4M | -22.1M | -5.8M | -12.1M | -6.4M | |
PRE-TAX INCOME | ||||||||
(0.0) | (0.0) | (201K) | (129K) | (486K) | (976K) | (1.5M) | (1.1M) | |
816K | 4.5M | 6.3M | 1.9M | 62K | -976K | -1.5M | -1.1M | |
(13.7M) | (81.1M) | (46.2M) | (0.0) | (0.0) | (12.5M) | (0.0) | (50K) | |
6.1M | 4.2M | 6.1M | 1.8M | -100K | -7M | -1.2M | -1.1M | |
-33.3M | -72.5M | -36.6M | -33.6M | -22.2M | -12.8M | -13.4M | -7.5M | |
NET INCOME | ||||||||
(62K) | -282K | -211K | (0.0) | (0.0) | (0.0) | (1.8M) | (50K) | |
19.5M | -72.2M | -36.4M | -33.6M | -22.2M | -12.8M | -15.2M | -7.5M |
SEC Filings
MASS - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 06, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 04, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 29, 2026 | June 11, 2026 | 2026 | |
S-3 S-3 N/A | March 09, 2026 | March 09, 2026 | ||
10-K 10-K 2025 FY FY | March 09, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 03, 2026 | March 03, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 20, 2026 | January 20, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 10, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 10, 2025 | November 10, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | August 05, 2025 | June 30, 2025 | 2025 |
Related Guides
Continue your MASS research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.